XDX REFERENCE LABORATORY

EUIPO EUIPO 2004 Application withdrawn

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark XDX REFERENCE LABORATORY was filed as Word mark on 12/21/2004 at the European Union Intellectual Property Office. The current status of the mark is "Application withdrawn".

Trademark Details Last update: February 8, 2024

Trademark form Word mark
File reference 004211231
Application date December 21, 2004
Publication date December 5, 2005

Trademark owner

8000 Marina Blvd., 4th Floor
94005 Brisbane,
US

Trademark representatives

Aurora Building, Counterslip BS1 6BX Bristol GB

Objection / Complaint

02/16/2006: Likelihood of confusion
Trademark
Applicant
REFERENCE LABORATORY, S.A.

goods and services

5 Biological chemical diagnostic test kits for clinical or medical laboratory use; biological chemical diagnostic test kits for clinical or medical laboratory use, namely, for use in analysis of gene expression, genetics, single nucleotide polymorphism, haplotypes, proteins, and biological samples, for use in detecting diseases, for use in determining the progression of diseases, and for use in determining drug responses; diagnostic medical reagents, chemicals and solid matrix materials for biological, clinical or medical laboratory use; diagnostic medical reagents, chemicals and solid matrix materials for biological, clinical or medical laboratory use, for use in diagnosing inflammatory, infectious, central nervous system, cardiovascular, neurological, endocrine, autoimmune and genetic diseases, development disorders and cancer
40 Manufacture of biological chemical diagnostic test kits for clinical or medical laboratory use; manufacture of biological chemical diagnostic test kits for clinical or medical laboratory use, namely, for use in analysis of gene expression, genetics, single nucleotide polymorphism, haplotypes, proteins, and biological samples, for use in detecting diseases, for use in determining the progression of diseases, and for use in determining drug responses; manufacture of diagnostic medical reagents, chemicals and solid matrix materials for biological, clinical and medical laboratory use for use in diagnosing inflammatory, infectious, central nervous system, cardiovascular, neurological, endocrine, autoimmune and genetic diseases, developmental disorders and cancer
42 Service provider of biological chemical diagnostic test kits for clinical or medical laboratory use, namely, for use in analysis of gene expression, genetics, single nucleotide polymorphism, haplotypes, proteins, and biological samples, for use in detecting diseases, for use in determining the progression of diseases, and for use in determining drug responses; diagnostic services; diagnostic services, namely, gene expression testing to determine immune response

Trademark history

Date Document number Area Entry
March 18, 2011 Change Representative, Published

ID: 11004211231